HA Filler

Beatrice Dermultra

Jawline, Brow and Cheekbone Contouring

A high-cohesion sodium hyaluronate gel containing lidocaine, designed for deep bone-structure shaping of the face. Stronger support and longer-lasting results, with a comfortable injection experience.

  • High cohesion, stronger support — deep structural facial shaping
  • Long-lasting performance — comparable to leading international premium products
  • Low-residue, high-safety design
  • Contains lidocaine — enhanced injection comfort
HA Content 24 mg/mL
Volume 1.0 mL
Presentation PFS
Store 2–30 °C, protect from direct sunlight
Full Specifications

Technical Data at a Glance.

CompositionCross-linked sodium hyaluronate, lidocaine hydrochloride
HA Content24 mg/mL
Lidocaine Content3 mg/mL
Volume1.0 mL per syringe
PresentationPre-filled syringe
BDDE Residue≤ 0.8 μg/g
IndicationsFor contour shaping and line optimisation of key bone-related facial areas — jawline, brow and cheekbone — improving jawline recession and facial proportion imbalance for a more defined, three-dimensional profile.
Duration12–18 months
StorageStore 2–30 °C · protect from direct sunlight · do not freeze
Diagram showing supraperiosteal placement of cross-linked hyaluronic acid for structural facial contouring

Mechanism of Action

Supraperiosteal Structural Support

Following supraperiosteal injection, cross-linked sodium hyaluronate provides space-occupying volume to refine osseous facial contours and compensate for local structural deficits. It supports contour refinement in areas including the jawline, brow ridge and zygomatic arch.

Illustration of high- and low-molecular-weight hyaluronic acid forming a graded cross-linked gel network

Technical Advantage

REFORMIX cross-linking technology uses high-molecular-weight HA to form a stable three-dimensional framework, while low-molecular-weight HA provides dense refinement. Together, they enhance gel cohesiveness and resistance to deformation, supporting stable, long-lasting three-dimensional contouring.

An optimised cross-linking pathway reduces both cross-linker use and residual cross-linker, supporting an improved safety profile and greater confidence in treatment.

Try Beatrice Dermultra for yourself.

Request a complimentary evaluation kit — product samples, full technical documentation, and specialist consultation. No commitment required.

We don't need to convince you — the product will.

Request Your Evaluation Kit →

Request a Sample of Beatrice Dermultra